Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Canaquest Medical Corp (OP:CANQF)

0.0001 UNCHANGED
Last Price Updated: 12:30 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Canaquest Medical Corp

News headline image
New Leaders Of NY Cannabis Reg Body And Recent Industry Appointments You Need To Know About ↗
Chris Alexander, the former head of the New York Office of Cannabis Management (OCM), resigned in May. Gov. Kathy Hochul first announced that Alexander's contract would not be renewed following its end... 
Via Benzinga
Topics Cannabis
News headline image
NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players
Via ACCESSWIRE
News headline image
CANAQUEST Announces Award of European Cannabinoid Patent
Via ACCESSWIRE
News headline image
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
Via ACCESSWIRE
News headline image
CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)
Via ACCESSWIRE
News headline image
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
Via ACCESSWIRE
News headline image
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated... 
Via iCrowdNewswire
News headline image
CBD Combined With Essential Fatty Acids Is 40% More Efficient In Epilepsy Seizure Reduction Than Regular CBD, New Study ↗
CANAQUEST MEDICAL CORP (OTCPK:CANQF), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous... 
Via Benzinga
News headline image
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
Via ACCESSWIRE
News headline image
The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More ↗
Cannabis stocks traded mostly in the green this week, as we got into earnings season. “While there were a lot of companies reportin... 
Via Benzinga
Topics Cannabis
News headline image
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
TORONTO, ON / ACCESSWIRE / April 29, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing formulations... 
From CanaQuest Medical Corp.
Via AccessWire
Topics Cannabis Intellectual Property
News headline image
Cannabis Movers & Shakers: CanaQuest, Terra Tech, BioSteel, Halo Collective, Rolling Stone Culture Council, Australis ↗
CanaQuest Names Wall Street Expert Rob Rinderman Director Of Communications CanaQuest Medical Corp (OTC PINK: CANQF) a biotechnology company focusing on cannabis, has hired Rob... 
Via Benzinga
Topics Cannabis
News headline image
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing health and wellness... 
From CanaQuest Medical Corp.
Via AccessWire
Topics Cannabis Initial Public Offering
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.